Actively Recruiting

Phase Not Applicable
Age: 50Years +
MALE
ID07115147

Blue Diode Laser Vaporization for Benign Prostatic Hyperplasia (BPH) in Men Aged 50 and Older

Led by Chinese University of Hong Kong · Updated on 2025-08-11

10

Participants Needed

1

Research Sites

12 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the outcomes of using a blue diode laser vaporization procedure to treat benign prostatic hyperplasia (BPH) in men aged 50 and older. The study follows a single group of participants over one year to observe how this 450nm blue laser treatment affects symptoms and prostate function. Researchers are collecting detailed data to understand the clinical progress and safety of this approach under medical supervision. Participants will receive the blue diode laser vaporization treatment performed under spinal or general anesthesia using a 200W blue light laser. Follow-up visits are scheduled at 3 months, 6 months, and 12 months after the operation to monitor recovery and treatment effects. During these visits, various tests and questionnaires will be repeated to assess prostate size, urinary flow, symptoms, and quality of life. Throughout the study, participants will undergo blood and urine tests, ultrasound scans to measure prostate volume, and uroflowmetry to check urine flow. The International Prostate Symptom Score (IPSS) and other questionnaires will be used to evaluate symptoms and quality of life. Researchers will also monitor any adverse events, unplanned hospital admissions, and changes in erectile and ejaculatory function. The total time commitment for each participant is one year from treatment to final follow-up.

CONDITIONS

Brief Title

Blue Diode Laser Vaporization for BPH

Who Can Participate

Age: 50Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male aged 50 years or older
  • Symptomatic benign prostatic hyperplasia (BPH)
Not Eligible

You will not qualify if you...

  • Need for additional procedures such as cystolithotripsy or orchidectomy
  • Known prostate cancer
  • History of transurethral resection of the prostate (TURP)
  • Known urethral stricture, bladder stone, or hypercontractile bladder
  • Known neurological diseases affecting bladder function (e.g. Parkinsonism, stroke)
  • Contraindications to TURP such as unfit for general or spinal anesthesia, active urinary tract infection, inability to assume lithotomy position, uncorrectable blood clotting issues, or use of antiplatelet/anticoagulant medications that cannot be stopped

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Surgery and Immediate Post-operative Care

Duration - Peri-operative period

Participants undergo blue diode laser vaporization of the prostate under spinal or general anesthesia, followed by immediate recovery and monitoring for peri-operative outcomes such as operation time, catheter use, and hospital stay.

1 surgical procedure and immediate post-operative monitoring

Post-operative Follow-up

Duration - 12 months

Participants are followed up to assess urinary symptoms, urodynamic changes, quality of life, and adverse events after surgery. Blood tests, urine tests, ultrasound, uroflowmetry, and questionnaires are completed to monitor clinical progress.

Visits at 1 month, 3 months, 6 months, and 12 months after surgery

Trial Site Locations

Total: 1 location

1

Prince of Wales Hospital, Chinese University of Hong Kong

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

K

Ka Fung Peter CHIU, MBChB PhD

K

Ka Fung CHIU

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Loop Diuretics During Morcellation to Improve Same-day Disch...

BPH With Urinary Obstruction

Actively Recruiting

1 location

A Study to Evaluate the Safety and Efficacy of Ionic Fluid i...

BPH (Benign Prostatic Hyperplasia)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

The prevalence of lower urinary tract symptoms in a Chinese population, and the correlation with uroflowmetry and disease perception.

Chi-Hang Yee, Joseph K M Li, Hon-Chung Lam...

https://pubmed.ncbi.nlm.nih.gov/24136186

Ambulatory care program for patients presenting with acute urinary retention secondary to benign prostatic hyperplasia.

Jeremy Yuen Chun Teoh, Chi Fai Kan, Bess Tsui...

https://pubmed.ncbi.nlm.nih.gov/22914880

Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis.

Jingfei Teng, Dongxu Zhang, Yao Li...

https://pubmed.ncbi.nlm.nih.gov/23145474